Evidence map›Paper›PMID 36985852›Full record

ArticleNanomaterials (Basel, Switzerland)2023

Ru(II) Complex Grafted Ti

Xiaofang Liu, Hongchi Xie, Shi Zhuo, Yuanhong Zhou, Mohamed S Selim, Xiang Chen, Zhifeng Hao

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Research Progress on TiMolecules (Basel, Switzerland) · 2024
    Review
  3. MXene: A wonderful nanomaterial in antibacterial.Frontiers in bioengineering and biotechnology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiaofang LiuKey Laboratory of Clean Chemistry Technology of Guangdong Regular Higher Education Institutions, School of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou 510006, China.
Hongchi XieKey Laboratory of Clean Chemistry Technology of Guangdong Regular Higher Education Institutions, School of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou 510006, China.
Shi ZhuoKey Laboratory of Clean Chemistry Technology of Guangdong Regular Higher Education Institutions, School of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou 510006, China.
Yuanhong ZhouKey Laboratory of Clean Chemistry Technology of Guangdong Regular Higher Education Institutions, School of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou 510006, China.
Mohamed S SelimKey Laboratory of Clean Chemistry Technology of Guangdong Regular Higher Education Institutions, School of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou 510006, China.
Xiang ChenKey Laboratory of Clean Chemistry Technology of Guangdong Regular Higher Education Institutions, School of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou 510006, China.ORCID 0000-0002-3016-620X
Zhifeng HaoKey Laboratory of Clean Chemistry Technology of Guangdong Regular Higher Education Institutions, School of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou 510006, China.

Funding

National Natural Science Foundation of China 52150410401Science and Technology Program of Guangzhou, China 202201010412
6 · The paper itself

Abstract

For a long time, the emergence of microbial drug resistance due to the abuse of antibiotics has greatly reduced the therapeutic effect of many existing antibiotics. This makes the development of new antimicrobial materials urgent. Light-assisted antimicrobial therapy is an alternative to antibiotic therapy due to its high antimicrobial efficiency and non-resistance. Here, we develop a nanocomposite material (Ru@MXene) which is based on Ru(bpy)(dcb)

Indexed as

antimicrobialMXenePTT/PDTRu complex

Identifiers

PMID36985852
PMCPMC10051588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.